Atlas Trials

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-718 Injection in Chinese Obese Subjects.

Clinical trial NCT06147544 · COMPLETED

Trial details

NCT number
NCT06147544
Sponsor
PegBio Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2023-07-06
Primary completion
2024-04-16
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.